कंपनी का अवलोकन
FitLife Brands, Inc. operates as a provider of nutritional supplements and wellness products catering to health-conscious consumers within the United States and international markets. The company's portfolio encompasses weight loss solutions, sports nutrition items, and general health products, with a specific strategic emphasis on natural, vegan, and organic formulations. This enterprise functions within the Consumer Defensive sector, specifically under the Packaged Foods industry, a classification that suggests a business model focused on essential goods where demand tends to remain relatively stable regardless of broader economic fluctuations. The company currently maintains a market capitalization of $92.69M, generates annual revenue of $81.46M, and employs 81 individuals to execute its operational strategy. These valuation and revenue figures indicate that FitLife Brands, Inc. is a small-cap entity with a modest operational footprint, suggesting that its financial resilience and growth potential are currently limited by its scale and available resources rather than diversified market presence.
वित्तीय स्वास्थ्य
The company reported a trailing twelve-month revenue of $81.46M, which resulted in a net income of $6.33M and an EBITDA of $13.60M. The significant disparity between the $81.46M revenue and the $6.33M net income reveals a cost structure where operating expenses, including the cost of goods sold, general administration, and selling expenses, collectively consume approximately 92.2% of total sales. While the EBITDA of $13.60M indicates a positive earnings before interest, taxes, depreciation, and amortization, the free cash flow stands at $-1,449,625, which signifies that the company is currently burning cash and lacks the immediate financial flexibility to fund internal expansion or acquisitions without external financing. Profitability is further dissected by three key margins: a gross margin of 39.9%, an operating margin of 12.1%, and a profit margin of 7.8%. The gross margin of 39.9% reflects the efficiency of production relative to sales, while the operating margin of 12.1% and profit margin of 7.8% demonstrate that roughly 7.2% of sales are absorbed by non-manufacturing costs and taxes before reaching the bottom line. On the balance sheet, the company holds $1.65M in cash against $45.27M in debt, resulting in a debt-to-equity ratio of 103.75%, which characterizes the capital structure as highly leveraged rather than conservative. Despite this high leverage, the current ratio of 1.53 suggests that the company possesses sufficient short-term liquid assets to cover its current liabilities, providing a baseline level of liquidity stability. Management effectiveness is evidenced by a Return on Equity of 15.9% and a Return on Assets of 10.0%, metrics that indicate the company is generating substantial returns relative to the shareholder equity and total assets employed, despite the heavy reliance on debt financing.
मूल्यांकन आकलन
Valuation multiples for FitLife Brands, Inc. show a Trailing Twelve Months (TTM) P/E ratio of 15.67 compared to a Forward P/E of 5.42. The substantial divergence between the trailing P/E of 15.67 and the forward P/E of 5.42 implies that the market expects a significant improvement in future earnings, potentially driven by anticipated operational efficiencies or volume expansion, although this also reflects the sensitivity of the current earnings base to recent performance fluctuations. The price-to-book ratio is recorded at 2.12, indicating that the market values the company at more than double its book value, which suggests a premium assigned to its intangible assets, brand equity, or growth prospects relative to its tangible asset base. Alternative valuation metrics include a price-to-sales ratio of 1.14 and an EV/EBITDA of 10.02; these figures suggest that the company is trading at a moderate multiple relative to its sales, while the EV/EBITDA of 10.02 places its valuation in a range often seen among capital-intensive sectors, though the high debt levels must be considered when interpreting this multiple. The stock's price volatility is contextualized by a 52-week high of $20.98 and a 52-week low of $9.71, meaning the current market price sits significantly closer to the low end of the trading range, specifically trading at approximately 53.4% below the 52-week high. The beta value is 0.38, which indicates that the stock's price volatility is substantially lower than the broader market, suggesting it behaves as a defensive asset that is less sensitive to systemic market swings compared to large-cap equities.
Growth & Income
Recent performance data highlights a revenue growth of 72.6% year-over-year contrasted with an earnings growth of -23.8% year-over-year. This dynamic indicates that earnings are growing significantly slower than revenue, or in this specific instance, declining while revenue expands, which implies that the top-line expansion is being offset by increasing costs, dilution, or one-time charges that are compressing the bottom line faster than sales are growing. Regarding income generation, the company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company reinvests all of its available earnings back into the business operations, research and development, or debt reduction rather than distributing cash to shareholders. The overall growth and income profile presents a scenario of aggressive top-line expansion that has not yet translated into proportional earnings growth, coupled with a capital allocation strategy focused entirely on internal reinvestment rather than shareholder returns.